Alivira Animal Health Limited (Ireland), a wholly owned subsidiary of SeQuent Scientific Limited (Mumbai), acquired 100% of the shares in Bremer Pharma GmbH (Germany) from Cadila Healthcare Limited on 17 April 2018.
Bremer Pharma is a veterinary health company in Germany with a portfolio of over 400 products across Europe, Far East, MENA, Russia & Africa operating in vitamins, antibiotics and hormones.
KPMG Law and KPMG AG (Germany) advised Alivira / SeQuent within the acquisition of Bremer Pharma via:
Legal Due Diligence, drafting and negotiation of share purchase agreement (SPA):
Maximilian Gröning (lawyer, Partner, KPMG Law Düsseldorf)
Andrea Bruns (lawyer, Senior Manager, KPMG Law Leipzig)
Julia Jakobs (lawyer, Senior Manager, KPMG Law Frankfurt.)
Tax Due Diligence, tax assistance in SPA
Christian Wotjak (certified tax advisor, Director, KPMG AG Leipzig)
Ruxandra Maria Pietzsch (certified tax advisor, Manager, KPMG AG Dresden)
Marcel Burow (certified tax advisor, Associate, KPMG AG Dresden)